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Predictors of 30-day 
mortality in medical patients 
with severe sepsis or septic 
shock
ABSTRACT
Objectives. To evaluate independent predictors of 30-day mortality in patients with severe sepsis or septic shock. 
Background. Severe sepsis and septic shock are associated with increased mortality. Admission APACHE II score is the 
gold standard for assessing prognosis in critically ill, but several other predictors of mortality have been evaluated. 
Methods. We retrospectively evaluated clinical and laboratory data in adult patients with severe sepsis or septic shock as 
predictors of 30-day mortality. 
Results. Thirty-day mortality was 62.7%. Nonsurvivors in comparison to survivors were significantly more likely to be trea-
ted with noradrenalin, renal replacement therapy, mechanically ventilated, to have suffered a fungal infection, had lower 
admission arterial pH, increased admission Acute Physiology, Age, Chronic Health Evaluation (APACHE) II score and a 
higher peak lactate level (5.6 ± 6.2 vs 3.1 ± 1.75, p=0.021). Binary logistic regression demonstrated that only peak in-
hospital serum lactate level was a significant independent predictor of 30-day mortality (OR 1.367, 95% CI 1.041 to 1.795, 
p=0.025). 
Conclusion. Only peak in-hospital lactate significantly and independently predicts 30-day mortality in severe sepsis or septic 
shock medical patients.
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Introduction
The incidence of severe sepsis is incre-
asing within the last decade, reaching 
50-100 cases /100.000 people in the 
general population and approximately 
30% in intensive care units. (1,2) Mor-
tality of patients with sepsis depends 
on the sepsis stage and co-morbiditi-
es. It ranges from 10-20% in patients 
with uncomplicated sepsis to 20-50% in 
severe sepsis and up to 80% in patients 
with septic shock. (1) 
Admission Acute Physiology, Age, 
Chronic Health Evaluation (APACHE) 
II score is a standard predictor of mor-
tality in critically-ill patients, including 
septic patients. (3) It is applicable in 
the majority of critically-ill patients and 
extensively validated in several coun-
tries due to its simplicity as a predictor 
of mortality. (4,5) The score is obtained 
from the patient’s age and the worst 
values of 12 physiological parameters 
within the first 24 hours such as body 
temperature, mean arterial blood pre-
ssure, pulse, arterial pO2, serum crea-
tinine, potassium, sodium, hematocrit, 
white blood cell count, Glasgow coma 
scale, respiratory rate. The higher the 
APACHE II score, the higher the mor-
tality rate. 
A variety of other predictors of mortality 
in patients with sepsis was evaluated 
in clinical studies, including inflamma-
tory markers such as C-reactive protein 
(CRP), lactate clearance, cardiac bio-
markers such as troponin and ejection 
fraction (EF), individual organ system 
failures, presence of multi-organ failure 
syndrome (MOFS), etc. (6) These stu-
dies were performed in heterogeneous 
patient populations, ranging from lower 
risk patients with sepsis to high risk 
septic shock patients, included from 
wards to surgical or medical intensive 
care units (ICU). (4-9) 
The primary objective of this study was 
to investigate which patient characteri-
stics are related to outcome in medical 
patients with severe sepsis or septic 
shock. 
Participants and methods
We performed a retrospective cohort 
analysis of all adult patients with seve-
re sepsis or septic shock treated in a 
medical ICU in 2008, 2009 and 2010. 
The study was approved by the Ehical 
institutional review board (No. 156/13) 
and is in accordance with the declarati-
on of Helsinki. 
In all, 102 patients (63 men, 39 women, 
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mean age 65.1 ± 13.3 years) were 
included. 
The criteria for severe sepsis were fulfi-
lled if in patients with sepsis there was 
at least one organ failure or a sign of 
tissue hypoperfusion. In septic shock 
patients there were signs of sepsis in 
addition to acute circulatory failure with 
decreased systolic blood pressure < 
90 mm Hg or mean arterial blood pre-
ssure < 65 mm Hg without any other 
known causes in spite of adequate infu-
sion of fluids. (10) 
Patient treatment followed guideline 
goals. (11) Adequate oxygenation was 
established by oxygen delivery with or 
without mechanical ventilation. Adequ-
ate perfusion was established by intra-
venous infusion of fluids, noradrenalin 
or dobutamine to reach mean arterial 
pressure > 65 mm Hg, central venous 
oxygen saturation (ScvO2) > 70% and 
urine output > 0.5 ml/kg/h within the first 
24 hours. EF < 50%, assessed by echo-
cardiography, confirmed systolic cardi-
ac dysfunction. Infection was controlled 
with intravenous antibiotics, administe-
red within an hour after prior microbio-
logical samples were withdrawn. Low 
dose hydrocortisone and insulin were 
administered if necessary. (11) 
Vital signs, laboratory test results, ICU 
treatment characteristics and final out-









Age (mean ± SD, years) 65.1 ± 13.3 63.82 ± 13.9 65.9 ± 12.9 0.452
Men (%) 61.8 60.5 62.5 0.99
APACHE II score (mean ± SD) 29.1 ± 8.3 26.6 ± 8.7 30.5 ± 7.8 0.020
S-glucose (mean ± SD, mmol/L) 12.7 ± 6.4 12.5 ± 25.8 12.9 ± 6.3 0.795
S-Lactate (mean ± SD, mmol/L) 3.8 ± 3.5 2.9 ± 1.9 4.3 ± 4.2 0.062
S-creatinine (mean ± SD, μmol/L) 224.8 ± 155.1 220.2 ± 159.1 227 ± 153.8 0.820
Arterial pH (mean ± SD) 7.28 ± 0.15 7.3 ± 0.1 7.2 ± 0.2 0.005
Pneumonias (%) 50.5 48.6 51.6 0.838
Uroinfection (%) 16.8 21.6 14.1 0.410
Other infections (%) 32.4 26.3 35.9 0.437
G + bacterial infection (%) 28.4 31.6 26.7 0.652
G – bacterial infecrion (%) 36.3 36.8 35.9 1.000
Viral infection (%) 2.9 2.6 3.1 1.000
Fungal infection (%) 14.7 5.3 20.3 0.045
Positive hemocultures (%) 52.9 50 54.7 0.685
APACHE, acute physiology, age, chronic health evaluation; G –, gram-negative; G +, gram-positive; SD, standard deviation.
p < 0.05 was statistically significant and was calculated by the two-sided Student’s t-test for means ± standard deviations and by the χ2-test 
for percentages. 





Survivors (n=38) Nonsurvivors (n=64) p
LVEDD  (cm) 4.9 ± 0.78 4.8 ±  0.6 5.0 ± 0.9 0.428
Ejection fraction (%) 39.7 ± 15.7 42.6 ± 13.7 38.1 ± 16.8 0.321
Peak serum glucose (mmol/L) 16.6 ± 6.7 16.4 ± 7.8 16.7 ± 6,1 0.822
Peak serum lactate (mmol/L) 4.7 ± 5.2 3.1 ± 1.8 5.6 ± 6.3 0.021
Peak serum creatinine (μmol/L) 304.0 ± 196.5 276.7 ± 190.8 320.2 ± 199.6 0.282
Peak serum CRP (mg/L) 220.2 ± 93.9 212.2 ± 90.8 225.0 ± 96.2 0.508
Peak troponin I (μg/L) 3.1 ± 6.5 3.5 ± 7.6 2.9 ± 5.8 0.721
Nadir serum albumin (g/L) 20.7 ± 12.2 22.7 ± 11.1 19.6 ± 12.8 0.227
Nadir serum glucose  (mmol/L) 5.4 ± 1.9 4.9 ± 1.5 5.6 ± 2.1 0.119
ICU stay (days) 11.7 ± 15.1 13.7 ± 12.7 10.6 ± 16.4 0.320
CRP, C-reactive protein;  ICU, intensive care unit;  LVEDD, left ventricular end-diastolic diameter; SD, standard deviation. 
p < 0.05 was statistically significant and was calculated by the two-sided Student’s t-test for means ± standard deviations and by the χ2-test 
for percentages
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come were retrieved from patient medi-
cal records. 
We registered demographic, admission 
and in-hospital laboratory and clinical 
data, treatments and 30-day mortality. 
Among laboratory data we registered 
admission and peak arterial pH, CRP, 
serum creatinine, lactate, troponin I and 
serum glucose as well as nadir serum 
glucose and albumin. Among clini-
cal data on admission we registered 
prior chronic diseases such as chronic 
cardio-vascular, pulmonary, hepatic, 
hematological, renal chronic disea-
se, admission mean arterial pressure, 
pulse, APACHE II score, ratio between 
arterial oxygen pressure and fraction of 
inspired oxygen (paO2/FiO2). 
Among organ failures we registered 
acute cardiovascular, respiratory, 
renal and hepatic failure.  Acute res-
piratory failure was defined as arterial 
hypoxia with paO2/FiO2 < 300, acute 
renal failure was defined as oliguria 
with increased serum creatinine, acute 
hepatic failure as an increase in serum 
bilirubin > 35 mmol/L and acute car-
dio-vascular failure as arterial hypo-
tension (decrease of systolic arterial 
blood pressure < 90 mmHg or mean 
arterial blood pressure < 65 mmHg). 
(10) We also registered positivity of 
hemocultures, site of infection – pne-
umonia, urinary tract infection and 
infection of other sites – in particular 
of pancreas, gall bladder, meninges, 
skin or joints. We registered causati-
ve microorganisms of infection asso-
ciated with sepsis as gram-negative 
and gram-positive bacteria, viruses or 
fungi, but we also registered microor-
ganisms (gram-negative, gram-positi-
ve bacteria, viruses or fungal infection) 
identified in positive hemocultures.
Among in-hospital data we registered 
echocardiographic parameters (ejecti-
on fraction and left ventricular end-dia-
stolic diameter) and treatments such as 
the use of noradenaline, inotropic sup-
port by dobutamine, mechanical ven-
tilation, iv. diuretics, insulin and renal 
replacement therapy by continuous 
veno-venous hemofiltration (CVVH). 
Our aim was to evaluate the indepen-
dent predictive role of demographic, 
clinical and laboratory data, treatments, 
individual organ failures and MOFS 
between survivors and nonsurvivors 
within 30 days in our patients with seve-
re sepsis and septic shock.  
Statistical analysis 
Statistical analysis was performed using 
SPSS statistical package, version 19 
(SPSS Inc., Chicago, IL, USA) for Win-
dows. Data were expressed as means 
± standard deviations or percenta-
ges. Differences between the groups 
were tested by the two-sided Student’s 
t-test for means ± standard deviations 
and by the χ2-test for percentages. A 
p-value < 0.05 was considered stati-
stically significant. The binary logistic 
regression model was used to predict 
relation to 30-day mortality. Goodness 
of fit of the model was assessed using 
the Hosmer-Lemeshow test.  
Results
During the inclusion period 102 patients 
were diagnosed with severe sepsis or 
septic shock. Baseline clinical data are 
displayed in table 1. In-hospital data 
are presented in table 2 and in-hospital 
MOFS, multi-organ failure syndrome.
CVVH, continuous veno-venous hemofiltration.
p < 0.05 was statistically significant and was calculated by the χ2-test for percen-
tages
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organ failures are displayed in figure 1. 
In-hospital treatments are presented in 
figure 2.  
30-day mortality of our patients with 
severe sepsis and septic shock was 
62.7%. 
Regarding admission clinical and labo-
ratory data we observed nonsignificant 
differences between survivors and non-
survivors in regard to mean age, gen-
der, admission serum glucose, creatini-
ne and lactate levels, in the incidence of 
pneumonia, urinary infection and other 
infections, in positive hemocultures, 
in the incidence of gram-positive and 
gram-negative bacterial infection and 
viral infection, but significant differen-
ces in fungal infection (5.3% vs 20.3%, 
p =0.045), in mean admission arterial 
pH (7.3 ± 0,1 vs 7.2 ± 0.2, p = 0.005) 
and APACHE II score (26.6 ± 8.7 vs 
30.5 ± 7.8, p = < 0.05) (table 1). 
Between survivors and nonsurvivors 
within 30 days we observed nonsigni-
ficant differences in in-hospital data 
such as mean levels of left ventricular 
end-diastolic diameter (LVEDD), EF, 
peak and nadir serum glucose and 
albumin levels, peak serum creatinine, 
troponin I and CRP levels, but signifi-
cant peak serum lactate levels (3.1 ± 
1.8 mmol/l vs 5.6 ± 6.3  mmol/l, p = 
0.021) (table 2). 
Between survivors and nonsurvivors 
within 30 days we observed nonsigni-
ficant differences in the incidence of 
MOFS, cardio-vascular, respiratory, 
renal and hepatic failures (figure 1).  
In treatments we observed nonsigni-
ficant differences between survivors 
and nonsurvivors within 30 days in 
dobutamine, diuretics and insulin, but 
significant differences in treatments 
by noradrenalin (73.6% vs 90.6%, p = 
0.045), mechanical ventilation (65.8% 
vs 85.9%, p = 0.024) and CVVH (7.9% 
vs 26.5%, p = 0.023) (figure 2). 
In terms of association with outcome, 
binary logistic regression demonstrated 
that peak in-hospital lactate level was 
the most significant independent predic-
tor of 30-day mortality (OR 1.367, 95% CI 
1.041 to 1.795, p = 0.025) (table 3).
Discussion
We observed that several clinical and 
laboratory data (admission arterial pH, 
APACHE II score, peak serum lactate, 
treatment with noradrenalin, mechani-
cal ventilation and CVVH, fungal infec-
tion) were associated significantly with 
30-day mortality in our patients with 
severe sepsis and septic shock. 
Thirty-day mortality in our patients with 
severe sepsis and septic shock was 
62.7%, which is similar to other studies. 
Treatment with noradrenalin, mechani-
cal ventilation and CVVH, significantly 
associated with mortality, pointed to a 
predictive role of pronounced cardio-
vascular, respiratory and renal failure 
for 30-day mortality in severe sepsis. 
(1,2) 
Mean admission APACHE II score as 
a gold standard for predicting morta-
lity was 29 in our patients, predicting 
approximately a 67.2% death rate and 
was associated significantly with 30-day 
mortality of our septic patients. (3)
Regarding microorganisms responsible 
for infection, gram-negative microorga-
nisms were still dominating and identi-
fied in 36.3% of patients in contrast to 
28.4% of gram-positive bacteria. 
According to the data in literature it was 
not surprising that fungal infections in 
our severely septic patients were signifi-
cantly associated with 30-day mortality. 
(12,13)  
However, binary logistic regression 
confirmed that only peak lactate levels 
significantly and independently pre-
dicted 30-day mortality in our septic 
patients.
Increased blood lactate levels in criti-
cally-ill patients in general are associa-
ted with increased morbidity and mor-
tality. (14,15) Patients with preserved 
blood pressure and elevated lactate 
levels are at increased risk of dying as 
well. (16,17) The importance of lactate 
levels is emphasized in the treatment 
of sepsis, where some treatment stra-
tegies as well as mortality risk depend 
on lactate levels. (11) A variety of other 
predictors of mortality have been evalu-
ated in clinical studies, including infla-
mmatory markers such as CRP, lactate 
clearance, cardiac biomarkers such as 
troponin and ejection fraction, multi-
organ failure syndrome, etc. (4-9)
Lactic acidosis is common in patients 
with severe sepsis or septic shock. The 
pathophysiology of lactic acidosis asso-
ciated with sepsis is not fully understo-
od. Both increased lactate production 
during anerobic and aerobic metabo-
lism and decreased clearance likely 
contribute to hyperlactemia. (18,19)  
Lactate-to-pyruvate ratio is elevated 
Table 3.  Binary logistic regression to estimate independent predictors of 30-day mortality in septic patients.
Variables χ2 OR p 95% C.I.
Admission pH 1.568 0.072 0.210 0.001 do 4.429
Noadrenalin therapy 3.272 4.336 0.070 0.885 do 21.249
Mechanical ventilation 1.178 1.954 0.278 0.583 do 6.553
CVVH 2.902 3.720 0.088 0.821 do 16.861
Peak serum  lactate 5.057 1.367 0.025 1.041 do 1.795
Admission  APACHE II 0.270 1.016 0.603 0.956 do 1.081
Fungal infection 2.361 3.849 0.124 0.690 do 21.470
APACHE, acute physiology and chronic health evaluation; CI, confidence interval; CVVH, continuous veno-venous hemofiltration; OR, odds 
ratio; χ2, chi2. 
p < 0.05 was statistically significant; Confidence intervals are at 95% probability 
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in septic shock, suggesting tissue 
hypoxia as the cause of lactic acido-
sis. Hyperlactemia in the absence of 
hypoxia has been documented as well. 
The additional possible mechanisms 
for hyperlactemia include activation of 
glycolysis and inhibition of pyruvate 
dehydrogenase. Some patients with 
sepsis have decreased lactate clearan-
ce rather than increased lactate produc-
tion. Hyperlactemia may be secondary 
to increased lactate production in the 
gut, liver, lungs, and skeletal muscles, 
decreased lactate clearance in the liver; 
or a combination of both. (18-20) 
Patients who have an arterial lactate 
level of more than 5 mmol/L experience 
poor outcomes, with mortality rate up to 
75% and median survival of 28 hours. 
Roughly 50% of these patients survive 
24 hours and about 20% are dischar-
ged from the hospital. (17,21,22) Mor-
tality rate is highest for patients with 
lactic acidosis (56%), compared with 
anion gap acidosis (39%). Serum lac-
tate, anion gap acidosis, phosphate, 
and age have been identified as inde-
pendent predictors of mortality. Overall, 
patients with metabolic acidosis were 
nearly twice as likely to die as patients 
without metabolic acidosis. (21) Pati-
ents with elevated lactate levels exhibit 
hospital mortality rates that increase 
almost linearly with the concentration 
of serum lactate. Several studies have 
shown that vigilant correction of hyper-
lactemia is associated with decreased 
morbidity and mortality. The mortality 
rate of patients with a serum lactate 
level greater than 2 mmol/L persisting 
after 24 hours, with associated acide-
mia, approaches 70%. (22)
Lactate as a marker of disease severity 
has a number of favourable properties. 
First, it can be withdrawn from both perip-
heral venous or arterial blood, making it 
possible to obtain lactate levels and to 
risk-stratify patients early, even in the 
emergency department. No significant 
differences exist between central veno-
us, peripheral venous or arterial lactate 
levels. (23) Second, a number of point-
of-care machines enable rapid, bedside 
determination of lactate levels. There 
seem to be no significant differences 
between point-of-care and laboratory 
lactate results. (24) Point-of-care lactate 
determination makes sense, especially 
when goal-directed therapy principles 
are to be observed. (24,25) Third, apart 
from recognition of critically ill patients, 
lactate tracking can be used as a tool 
to evaluate the efficacy of treatment not 
only in sepsis, but in variety of settings. 
(11,24) Third, the information that ele-
vated lactate levels provide, is easily 
integrated into treatment strategies, no 
additional conversions or calculations 
are needed. 
To conclude, the results of our study 
confirm the importance of measuring 
lactate levels on a regular basis in criti-
cally ill patients with severe sepsis and 
septic shock. Increased levels of lactate 
enable recognition of patients who are 
at highest risk of dying. The method is 
simple and can be performed at the 
bedside. The information that elevated 
lactate levels provide to the clinician is 
easily integrated into existing treatment 
strategies. No additional conversions 
or calculations are needed in order to 
appreciate the results. Peak in-hospital 
lactate level was the only significant 
independent predictor of 30-day mor-
tality in our patients with severe sepsis 
and septic shock.
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